Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Isarna Therapeutics GmbH
DescriptionSelective transforming growth factor (TGF) beta 2 (TGFB2) inhibitor
Molecular Target Transforming growth factor (TGF) beta 2 (TGFB2)
Mechanism of ActionTransforming growth factor (TGF) beta 2 inhibitor
Therapeutic ModalityNucleic acid: Linear DNA
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat advanced glaucoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today